Clinical Trial Update: A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update comparing two bevacizumab-based regimens for metastatic colorectal cancer, with the study status listed as terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Colorectal Cancer | Phase 4 | Status: TERMINATED